Log In
Print this Print this

Therapeutic HCV vaccine

Also known as: TerCvax

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionVaccine composed of replication-defective adenovirus vector (chimpanzee-derived serotype 3 (AdCh3) and MVA that encode the non-structural (NS) proteins NS3-5
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsVaccinate against hepatitis C virus (HCV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today